BIOSPAIN 2026 and the UK: Connecting two leading biotech ecosystems to drive innovation an... 24/06/2026 Healthcare International BioSpain The United Kingdom will be the Guest Nation at BIOSPAIN 2026, underscoring the event’s growing international relevance... AseBio
GENESIS Biomed contributes to the development of growth strategies for KYMOS and other C... 23/06/2026 Healthcare Financing Corporate ACCIÓ’s Noves Oportunitats de Negoci calls for proposals provide Catalan companies with a supportive framework for... Partners - GENESIS Biomed
Cardiovascular Device Development: KOL Insights for Innovators Online Del 16/07/2026 17:00 to 16/07/2026 18:00 Healthcare Access to innovation International
World ALS Day | “ALS research is currently going through a particularly promising moment” 21/06/2026 Healthcare Rare diseases Innovative drugs Personalized medicine We interview Alfonso de Egaña Barrenechea, CEO of Molefy Pharma, a company developing AP-2, an innovative molecule... AseBio - MOLEFY PHARMA
Research on the TDP-43 protein opens new therapeutic avenues for ALS 20/06/2026 Biotechnology is driving new strategies to combat ALS, including research on the TDP-43 protein, a key target involved... AseBio
The University of Barcelona Science Park reaches a new investment record of €230 million ... 16/06/2026 Healthcare Innovative drugs Financing The University of Barcelona Parc Científic de Barcelona (PCB-UB) broke its investment record in 2025, with a total of... Partners - Parc Científic de Barcelona
Shilpa Biocare Invests in Gate2Brain to Advance G2B-002, an Innovative Brain Cancer Thera... 16/06/2026 Healthcare Rare diseases Innovative drugs Gate2Brain signs a strategic partnership with Shilpa Biocare, including a €7 million investment for a 30.4% equity stake... Partners - Gate2Brain
Stablepharma and AFT Move to Expand Fridge-Free Vaccine Distribution Following Positive Cl... 15/06/2026 Healthcare Innovative drugs International Potential agreement follows positive clinical and stability data, supporting rollout in UK, Canada, Australia and New... Partners - STABLEPHARMA
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health... 27/07/2026 Healthcare Innovative drugs Oriva is developing innovative medicines for chronic gynaecological diseases and is backed by pre-seed financing from... Partners - Asabys Partners
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia ... 11/06/2026 Healthcare Drug discovery Innovative drugs In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity... Partners - Oryzon Genomics
